Navigation Links
New insights contradict promising Alzheimer's research
Date:5/23/2013

Approximately a year ago, the leading journal Science published an article about bexarotene as a potential Alzheimer's drug. A significant breakthrough and an important starting point for further Alzheimer's research. The research group of Bart De Strooper Alzheimer's researcher at VIB and KU Leuven in collaboration with the group of Rudi D'Hooge KU Leuven and scientists at Janssen Pharmaceutica, Beerse, also tested this candidate drug in various Alzheimer's animal test models. Their results were different, as were those of two American study groups. Therefore, they have recommended in a "technical comment" in Science that bexarotene should not be tested on patients.

Bart De Strooper (Department Director VIB/KU Leuven): "Science is a learning process and one learns by trial and error and by starting again and correcting mistakes. Therefore, it is logical that conclusions from scientific research even in prestigious journals need to be re-evaluated from time to time. If results cannot be reproduced, it is very important that this is mentioned so that other scientists can also determine the value of a publication (reproducible science is the only true science). This is the only way that we can learn from our mistakes and hopefully one day develop a drug."

Jo Bury (Managing Director VIB): "VIB places great value on thorough checks and balances of scientific results. This is the most important condition for leading research that could benefit our society. It is good news that Science is also prepared to publish negative results."

Scientific research, a process of ups and downs

Scientific findings do not simply fall into someone's lap; they are the result of years of dogged research. The icing on the cake is a publication in a scientific journal, as this is the way that scientists announce their results to the world. Before a publication is accepted, a journal will submit the document to a panel of leading scientists in that field of research. The publication is only given the go-ahead following a positive evaluation by these experts.

Built-in control mechanisms

Is this an absolute guarantee? Unfortunately not.

Fellow scientists try to reproduce results. They are usually successful, but sometimes similar experiments lead to different results. And this needs to be reported and examined in more detail. These built-in control mechanisms in the scientific process are therefore very important. It is a normal part of the scientific process. Scientific journals also sometimes offer scientists the opportunity to comment on certain publications after they have been published. The journal Science does this in the form of "technical comments". This is often the source of more extensive research.

New insights sometimes invalidate existing theories

Scientists want to get to the bottom of phenomena, usually with a certain hypothesis in mind. Research leads to new knowledge and insights, which results in refinement of the existing theories. However, sometimes this results in a completely new theory and the rejection of an existing theory. The history of science is littered with examples of this: think of Copernicus who was the first to assert that the sun and not the earth is the centre of our solar system. The Flemish contribution to Science is an excellent example of the self-monitoring process in the scientific world.


'/>"/>

Contact: Kris Van der Beken
kris.vanderbeken@vib.be
0032-473-783-435
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Related medicine news :

1. BroadConnect’s Latest Video Solution Sets Aimed at Providing Technical Insights for Businesses Hoping to Gain Greater Returns from their Investment in Communication and Security Solutions
2. NexTec Group Named to Bob Scott’s Insights Top 100 VAR’s for 2013
3. Julia Desmond Talks Deeksha Dynamics and 108 Insights to Empowerment in New Book
4. Gaspari Nutrition Sponsors Renzo Gracie Jiu Jitsu’s Weekly Insights Video Series
5. Monkey Research Gives Insights Into New SARS-Like Virus
6. RazorInsights Hires Former Siemens RVP Karl Kiss to Drive Sales
7. More Genetic Insights Into 3 Types of Cancer
8. Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors
9. Pulmonary & Allergy Update highlights insights and advances
10. Study of cancer cell metabolism yields new insights on leukemia
11. Studies provide new insights into brain-behavior relationships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: